Otsuka Group News

Otsuka Holdings Receives the IR Special Award for the First Time at the 2026 IR Award

  • Otsuka Holdings

November 12, 2026

Otsuka Holdings Co., Ltd. (Head office: Chiyoda-ku, Tokyo, Japan; President and Representative Director, CEO: Makoto Inoue) received the IR Special Award at the 2026 IR Award organized by the Japan Investor Relations Association (JIRA), marking the first time Otsuka Holdings has received the award. The award recognizes Otsuka Holdings’ enhanced communication of its growth strategy and investments for growth through its Integrated Report, its detailed briefing on a major acquisition, and its focus on providing information on R&D.

The IR Award recognize companies which have been highly accredited in the investment community for their understanding and promotion of IR activities. This year marks the 31st year since the first IR Award. A total of 359 companies applied this year, with 13 selected for recognition: two for the IR Grand Prix Award, six for the Best IR Award, three for the IR Special Award, and two for the Best IR Award for Encouragement.

The IR Special Award that Otsuka Holdings received recognizes companies, among IR Award applicants, that take on a leadership role in IR activities in their respective industry, consistently improve IR practices, and are highly regarded for promoting their IR to individual investors.

The reasons cited for Otsuka Holdings’ receipt of the award were:
● In recent years, Otsuka Holdings' management has placed greater emphasis on IR and has been enhancing its IR activities.
● In its Integrated Report, the Message from the CEO outlines the key points of the company’s growth strategy and provides clear explanations of growth investments and returns, as well as progress in cash generation.
● The company has also increased the frequency of its briefing sessions and held detailed briefings on major acquisitions.
● Otsuka Holdings is also enhancing its disclosure of R&D data and explanations of its strategies to encourage a better understanding of its management approach aimed at sustainably enhancing corporate value.
● The company also holds events designed to foster an understanding of its corporate culture.

Guided by its corporate philosophy, Otsuka-people creating new products for better health worldwide, the Otsuka group operates a diverse portfolio of businesses globally, including its Pharmaceutical Business, which covers the wide spectrum from diagnosis to treatment of diseases, and its Nutraceutical*Business, which supports maintenance and promotion of everyday health through products and services based on scientific evidence.

As a total healthcare company that takes a comprehensive approach to the diverse social issues related to health, the group will continue to deliver unique value that supports each individual’s health and way of life.

The Otsuka group will continue to proactively communicate information about these business activities and initiatives and engage in ongoing dialogue with stakeholders in order to further enhance corporate value.

*Nutraceuticals (NC): nutrition + pharmaceuticals)

Reference
Otsuka Group Investor Relations
https://www.otsuka.com/en/ir/

Otsuka Group Integrated Report 2026
https://www.otsuka.com/en/ir/library/annual.html

Japan Investor Relations Association (JIRA)
https://www.jira.or.jp/english/

TOP